Kadmon consultant charged with insider trading ahead of biotech’s $1.9B sale to Sanofi: SECnews2022-05-25T14:45:51+00:00May 25th, 2022|Fierce Pharma|
Verrica Pharma’s viral skin condition drug gets rejected—again, with its CMO flagged for deficienciesnews2022-05-25T14:33:30+00:00May 25th, 2022|Fierce Pharma|
Pfizer reveals plan to make its products available to 45 poor countries at not-for-profit costnews2022-05-25T13:57:24+00:00May 25th, 2022|Fierce Pharma|
Kyowa Kirin goes for the glow to bring awareness to rare bone disease XLHnews2022-05-25T13:30:17+00:00May 25th, 2022|Fierce Pharma|
J&J’s Momenta calls infringement against Viatris’ Copaxone generic, but why now?news2022-05-25T13:05:10+00:00May 25th, 2022|Fierce Pharma|
Bavarian Nordic signs ‘larger’ monkeypox vaccine supply deal with unnamed countrynews2022-05-25T12:38:15+00:00May 25th, 2022|Fierce Pharma|
Almirall, ramping up its Klisyri launch, wants patients to ‘listen to what your marks whisper to you’news2022-05-25T09:13:20+00:00May 25th, 2022|Fierce Pharma|
ASCO: Is another pan-tumor drug on the horizon? Johnson & Johnson thinks Balversa could be itnews2022-05-25T08:39:17+00:00May 25th, 2022|Fierce Pharma|
PTSD treatment startup’s billboards speak to healthcare workers, first responders: ‘Your Trauma is Valid’news2022-05-25T01:54:33+00:00May 25th, 2022|Fierce Pharma|
Pfizer to expand Michigan manufacturing site to support Paxlovid rollout: reportnews2022-05-24T20:30:56+00:00May 24th, 2022|Fierce Pharma|
